Alan Cruess



Phone: 902-473-7215
Fax: 902-473-2839
Mailing Address: 
Department of Ophthalmology & Visual Sciences
QEII Health Sciences Centre
2035-2 West Victoria Building
1276 South Park Street

Halifax, NS B3H 2Y9
Research Topics:
  • Clinical trials in new technology for macular degeneration
  • Diabetic retinopathy
  • Retinal imaging
  • Vision health policy
  • Retinal vascular obstruction


  • MD (Queen’s University)
  • Retina Fellowship (Wills Eye Hospital)

Selected publications

  • Cruess, AF, Berger A, Colleaux K, Greve M, Harvey P, Kertes P, Sheidow T, Tourville E, Williams G, Wong D. Canadian Expert Consensus: Optimal Treatment of Neovascular Age-Related Macular Degeneration. Can J Ophthalmol 2012; 47(3): 227-235
  • Gordois A, Cutler H, Pezzullo L, Gordon K, Cruess A, Winyard S, Hamilton W, Chua K. "An Estimation of the Worldwide Economic and Health Burden of Visual Impairment" Glob Public Health. 2012;7(5):465-81. cloi: 10.1080/17441692. 2011.634815. Epub 2011 Dec 5
  • Hooper P, Boucher MC, Colleaux K, Cruess A, Greve M, Lam WC, Shortt S,Tourville, E. Contemporary Management of Diabetic Retinopathy in Canada: from guidelines to algorithm guidance Ophthalmologica. 2014; 231(1): 2-15. doi:10.1159/000354548. Epub 2013 Nov 12
  • Cruess AF, Giacomantonio N. Cardiac Issues of Noncardiac Drugs: The Rising Story of Avastin in Age-related Macular Degeneration. Ophthalmologica. 2014; 231(2): 75-79 doi: 10.1 159/000355569. Epub 2013 Nov 2

Selected awards & honours

  • Medals in Medicine & Surgery (Queen's University, 1975)
  • Bayer Award for Innovation, Science for a Better Life (2013)


  • Queen's University, 1983-2003
  • Dalhousie University, 2003-present

Service & activity

  • President, Canadian Ophthalmological Society, 2006-2008
  • CNIB national board member, 2014-present